372.04
1.40%
-5.29
After Hours:
372.04
Overview
News
Price History
Option Chain
Why WST Down?
Discussions
Forecast
Stock Split
Dividend History
West Pharmaceutical Services, Inc. stock is currently priced at $372.04, with a 24-hour trading volume of 435.77K.
It has seen a -1.40% decreased in the last 24 hours and a -5.98% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $376.8 pivot point. If it approaches the $368.5 support level, significant changes may occur.
West Pharmaceutical Services, Inc. Stock (WST) Financials Data
West Pharmaceutical Services, Inc. (WST) Revenue 2024
WST reported a revenue (TTM) of $2.95 billion for the quarter ending December 31, 2023, a +2.18% rise year-over-year.
West Pharmaceutical Services, Inc. (WST) Net Income 2024
WST net income (TTM) was $593.40 million for the quarter ending December 31, 2023, a +1.28% increase year-over-year.
West Pharmaceutical Services, Inc. (WST) Cash Flow 2024
WST recorded a free cash flow (TTM) of $414.50 million for the quarter ending December 31, 2023, a -5.67% decrease year-over-year.
West Pharmaceutical Services, Inc. (WST) Earnings per Share 2024
WST earnings per share (TTM) was $7.88 for the quarter ending December 31, 2023, a +2.07% growth year-over-year.
West Pharmaceutical Services, Inc. Stock (WST) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Winters Chad | VP, Chief Accounting Officer |
Mar 11 '24 |
Option Exercise |
173.22 |
675 |
116,924 |
2,124 |
Winters Chad | VP, Chief Accounting Officer |
Mar 11 '24 |
Sale |
358.82 |
815 |
292,436 |
1,309 |
Witherspoon Charles | VP & Treasurer |
Feb 28 '24 |
Option Exercise |
102.51 |
2,019 |
206,968 |
3,998 |
Witherspoon Charles | VP & Treasurer |
Feb 28 '24 |
Sale |
358.62 |
2,019 |
724,061 |
1,979 |
Green Eric Mark | President, CEO and Board Chair |
Feb 27 '24 |
Option Exercise |
57.38 |
73,132 |
4,196,314 |
217,040 |
Green Eric Mark | President, CEO and Board Chair |
Feb 27 '24 |
Sale |
359.85 |
64,132 |
23,077,971 |
152,908 |
Abraham Silji | SVP, Chief Technology Officer |
Feb 23 '24 |
Option Exercise |
173.22 |
7,012 |
1,214,619 |
11,672 |
Abraham Silji | SVP, Chief Technology Officer |
Feb 23 '24 |
Sale |
365.00 |
7,012 |
2,559,380 |
4,660 |
Winters Chad | VP, Chief Accounting Officer |
Dec 01 '23 |
Option Exercise |
156.18 |
797 |
124,472 |
2,283 |
Winters Chad | VP, Chief Accounting Officer |
Dec 01 '23 |
Sale |
349.00 |
1,013 |
353,541 |
1,270 |
West Pharmaceutical Services, Inc. Stock (WST) Latest News
West Pharmaceutical Services (WST) Expected to Beat Earnings Estimates: Should You Buy?
Zacks Investment Research
Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
Zacks Investment Research
Merit Medical (MMSI) Down 0.6% Since Last Earnings Report: Can It Rebound?
Zacks Investment Research
Why Is Henry Schein (HSIC) Down 1.8% Since Last Earnings Report?
Zacks Investment Research
Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
Zacks Investment Research
Strength Seen in West Pharmaceutical (WST): Can Its 5.7% Jump Turn into More Strength?
Zacks Investment Research
About West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, and washing and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including CZ, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as specialized testing services for drug packaging, devices, and administration systems. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
Cap:
|
Volume (24h):